글로벌 임상 위험군 분류 솔루션 시장 – 2023-2030

Global Clinical Risk Grouping Solutions Market - 2023-2030

상품코드HCIT5267
발행기관DataM Intelligence
발행일2023.06.12
페이지 수195 Pages
포맷PDF + EXCEL
커버리지Global

₩6,525,000 – ₩11,775,000

보고서 요약(국문)

시장 개요
글로벌 임상 위험군 분류 솔루션 시장 규모는 2022년 6억 431만 달러에 달했으며, 2030년까지 16억 5,883만 달러로 성장할 것으로 예상됩니다. 이 시장은 예측 기간(2023~2030년) 동안 연평균 13.9%의 성장률을 보일 것으로 전망됩니다. 의료 분야의 위험 관리는 환자에 대한 위험을 감지, 모니터링, 평가, 완화 및 예방하기 위해 설계된 복잡한 시스템, 프로세스, 절차 및 보고 체계입니다.
임상 위험군 분류 솔루션 시장은 가치 기반 의료, 의료비 상승, 인구 건강 관리, 데이터 분석 및 기술, 규제 및 상환 정책 변화, 의료 서비스 조정 개선, 환자 중심 접근 방식 등의 요인에 의해 성장하고 있습니다.
그러나 임상 위험군 분류 솔루션 시장의 성장에는 여러 가지 제약 요인이 존재합니다. 이러한 제약 요인에는 비용 및 예산 제약, 변화에 대한 저항, 분산된 의료 시스템, 데이터 개인정보 보호 및 보안 문제, 인식 및 교육 부족, 규제 및 법적 문제 등이 포함됩니다.

시장 동향
가치 기반 진료에 대한 관심 증가
가치 기반 진료는 비용을 관리하면서 환자 치료 결과를 개선하는 데 중점을 두는 모델입니다. 이는 의료 시스템의 초점을 기존의 진료비 지불 방식에서 품질, 효율성, 환자 만족도를 보상하는 가치 기반 진료로 전환하는 것입니다.
임상 위험 관리 솔루션은 환자 치료 결과를 저해할 수 있는 위험을 식별하고 관리하는 데 중요한 역할을 합니다. 이러한 솔루션은 의료 기관이 품질 지표를 모니터링하고, 개선 영역을 파악하며, 위험을 완화하고 환자 안전을 강화하는 전략을 구현하는 데 도움을 줍니다.
또한 효과적인 진료 조정 및 전환, 성과 측정 및 보고, 비용 절감 및 효율성 향상, 인구 건강 관리 등을 지원할 수 있습니다. 이러한 솔루션은 의료 기관이 부작용을 예방하고, 재입원을 줄이며, 전반적인 인구 건강 결과를 개선하기 위한 사전 예방적 전략을 구현하는 데 도움이 됩니다.
규제 및 법적 과제
의료 환경에서 임상 위험 관리 솔루션은 데이터 개인정보 보호 및 보안, 규정 준수, 표준화 및 상호 운용성 등 다양한 규제 및 법적 과제에 직면해 있으며, 이는 시장 성장을 저해하는 주요 요인입니다.

GDPR(일반 데이터 보호 규정) 및 HIPAA(건강 보험 이동성 및 책임법)와 같은 데이터 개인정보 보호 규정은 솔루션 제공업체가 시스템을 이러한 규정에 준수하도록 보장하는 데 필수적입니다. 규정 준수를 위해서는 의료 기관이 이상 사례 보고, 사건 관리 및 품질 보고를 해야 합니다.
일관된 데이터 형식, 용어 및 통신 프로토콜의 부족으로 인해 표준화 및 상호 운용성이 어려울 수 있습니다. 솔루션 제공업체는 상호 운용성 표준을 마련하고 다른 이해 관계자와 협력하여 임상 위험 솔루션과 기존 의료 IT 인프라 간의 원활한 통합 및 데이터 공유를 보장해야 합니다.
COVID-19 영향 분석
COVID-19 팬데믹은 환자 안전에 대한 관심 증가, 원격 의료 및 원격 모니터링 서비스 도입 확대, 데이터 분석 및 감시 기능 강화 등으로 인해 임상 위험 그룹화 솔루션 시장에 상당한 영향을 미쳤습니다. 이로 인해 감염성 질환 및 기타 이상 사례와 관련된 위험을 식별하고 줄이는 데 도움이 되는 임상 위험 솔루션에 대한 수요가 증가했습니다.

원격진료 및 원격 모니터링 서비스가 확대되었으며, 강력한 데이터 분석 기능을 갖춘 임상 위험 솔루션은 코로나19 관련 데이터를 추적 및 분석하는 데 중요한 역할을 하여 의료기관과 공중보건 기관이 위기에 효과적으로 대응할 수 있도록 지원했습니다. 팬데믹으로 인해 의료 서비스 제공 방식에 대한 규제 변화와 유연성 증대가 필요해졌습니다. 안전을 보장하기 위해 원격 근무 정책과 가상 협업 도구가 도입되었습니다.
러시아-우크라이나 분쟁 분석
러시아-우크라이나 분쟁은 양국의 임상 위험 그룹화 솔루션 시장에 상당한 영향을 미쳤습니다. 의료 인프라 파괴, 의료 전문가 이동, 재정 자원 부족, 규제 및 법적 문제, 데이터 교환 및 상호 운용성 중단, 지정학적 불안정으로 인한 불확실한 시장 환경 등이 그 예입니다. 의료기관과 솔루션 제공업체는 변화하는 규제에 대응하고 솔루션이 변화하는 환경에 부합하도록 해야 할 수도 있습니다. 또한 이 분쟁은 양국의 임상 시험에도 부정적인 영향을 미쳤습니다.
세분화 분석
글로벌 임상 위험 그룹화 솔루션 시장은 제품, 배포 방식, 최종 사용자 및 지역별로 세분화됩니다.

제품 유형별 분석: 대시보드 및 데이터 시각화 도구 부문이 시장 점유율을 주도할 것으로 예상
제품 유형별로는 대시보드 및 데이터 시각화 도구 부문이 예측 기간 동안 38.7%의 시장 점유율을 차지하며 시장을 주도할 것으로 예상됩니다. 이는 결제 프로세스 예측, 결제 ​​위험 분석, 임상 데이터 이해 용이성 등의 장점 때문입니다. 의료 산업에서 빅데이터 및 AI와 같은 최신 기술에 대한 수요 증가와 의료 서비스 가격 인하를 위한 노력 확대가 시장 성장을 견인할 것으로 전망됩니다. 또한, 만성 질환 유병률 증가와 데이터 관리 분야에서 클라우드 서비스 활용 증가가 전 세계 임상 위험 그룹화 솔루션 시장의 성장을 촉진할 것으로 예상됩니다.
지역별 분석
북미, 기술적으로 선진화된 의료 인프라를 바탕으로 2022년 시장 점유율 약 40.2% 차지
북미는 기술적으로 선진화된 의료 인프라를 바탕으로 임상 위험 그룹화 솔루션 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 북미 지역이 이 시장을 주도하는 데에는 여러 요인이 작용합니다. 선진 의료 시스템, 규제 환경, 풍부한 재정 자원, 연구 개발, 품질 및 환자 안전, 그리고 품질 및 환자 안전에 대한 높은 관심 등이 그 예입니다.
이러한 요인 덕분에 북미 지역의 의료 기관들은 환자 안전 및 위험 관리를 강화하기 위한 임상 위험 솔루션을 신속하게 도입하고 실행할 수 있습니다. 북미 의료 시스템은 임상 위험 그룹화 솔루션 시장에서 품질 개선과 환자 안전을 매우 중요하게 생각합니다.
경쟁 환경
이 시장의 주요 글로벌 기업으로는 3M, Optum, Conduent, Lightbeam Health Solutions, Health Catalyst, Change Healthcare, Milliman, COTIVITI, Episource, Med-IQ 등이 있습니다.
보고서 ​​구매 이유

• 제품, 배포 방식, 최종 사용자 및 지역별 글로벌 임상 위험 그룹화 솔루션 시장 세분화를 시각화하고 주요 사업 자산 및 기업을 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 모색합니다.

• 모든 세그먼트를 포함한 임상 위험 그룹화 솔루션 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다. • PDF 보고서는 철저한 질적 인터뷰와 심층 연구를 바탕으로 한 종합적인 분석 자료로 구성됩니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료는 Excel 파일로 제공됩니다.
글로벌 임상 위험군 분류 솔루션 시장 보고서는 약 54개의 표, 46개의 그림, 그리고 195페이지 분량으로 구성됩니다.
2023년 주요 고객층
• 제조업체/구매자
• 산업 투자자/투자은행
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Clinical Risk Grouping Solutions Market size reached US$ 604.31 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 1,658.83 million by 2030. The market is exhibiting at a CAGR of 13.9% during the forecast period (2023-2030). Risk management in healthcare is a complex set of systems, processes, procedures, and reporting structures designed to detect, monitor, assess, mitigate, and prevent risks to patients.
The market for clinical risk grouping solutions is driven by factors such as value-based care, rising healthcare costs, population health management, data analytics and technology, regulatory and reimbursement changes, improved care coordination, and a patient-centric approach.
The clinical risk grouping solutions market has several restraints that can affect its development. These include cost and budgetary constraints, resistance to change, fragmented healthcare systems, data privacy and security concerns, limited awareness and training, and regulatory and legal challenges.
Market Dynamics
Rising Focus On Value-Based Care
Value-based care is a model that emphasizes improving patient outcomes while controlling costs. It shifts the healthcare system's focus from a fee-for-service approach to value-based care that rewards quality, efficiency, and patient satisfaction.
Clinical risk solutions play a crucial role in identifying and managing risks that could compromise patient outcomes. These solutions help healthcare organizations monitor quality metrics, identify areas for improvement, and implement strategies to mitigate risks and enhance patient safety.
They can also facilitate effective care coordination and transitions, perform performance measurement and reporting, cost containment and efficiency, and population health management. These solutions can help healthcare organizations implement proactive strategies to prevent adverse events, reduce hospital readmissions, and improve overall population health outcomes.
Regulatory and Legal Challenges
Clinical risk solutions in healthcare settings face a variety of regulatory and legal challenges, the main factor hampering the market. The regulatory and legal challenges such as data privacy and security, regulatory compliance, and standardization and interoperability.
Data privacy regulations such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA) are essential for solution providers to ensure their systems comply with these regulations. Regulatory compliance requires healthcare organizations to report adverse events, incident management, and quality reporting.
Standardization and interoperability can be challenging due to a lack of uniform data formats, terminology, and communication protocols. Solution providers should work towards interoperability standards and collaborate with other stakeholders to ensure smooth integration and data sharing between clinical risk solutions and existing healthcare IT infrastructure.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the clinical risk grouping solutions market, with the increased focus on patient safety, increased adoption of telehealth and remote monitoring services, and enhanced data analytics and surveillance capabilities. This has led to a greater demand for clinical risk solutions that can help identify and reduce risks associated with infectious diseases and other adverse events.
Telehealth and remote monitoring services have also been expanded, and clinical risk solutions with robust data analytics capabilities were instrumental in tracking and analyzing COVID-19-related data, enabling healthcare organizations and public health agencies to respond effectively to the crisis. The pandemic necessitated regulatory changes and increased flexibility in healthcare delivery. Remote work policies and virtual collaboration tools were implemented to ensure safety.
Russia-Ukraine Conflict Analysis
The Russia-Ukraine conflict has had a significant impact on the clinical risk grouping solutions market in both countries including disruption of healthcare infrastructure, displacement of healthcare professionals, limited financial resources, regulatory and legal challenges, data exchange and interoperability disruption, and an uncertain market environment due to geopolitical instability. Healthcare organizations and solution providers may need to navigate evolving regulations and ensure their solutions align with the changing landscape. The war also negatively impacted the clinical trials in both countries.
Segment Analysis
The global clinical risk grouping solutions market is segmented based on product, deployment, end-user, and region.
Based on Product, Dashboard And Data Visualization Tools Segment is Expected To Dominate The Market Share
Based on the product, the dashboard and data visualization tools segment is expected to dominate the market share of 38.7% during the forecast period due to its ability to predict payment processes, payment risk, and ease of comprehension of clinical data. The demand for modern technologies such as big data and AI in the healthcare industry and increased initiatives to reduce the prices of healthcare services are expected to drive market expansion. In addition, rising chronic illness prevalence and increased use of cloud services in data management are likely to drive growth in the worldwide clinical risk grouping solutions market.
Geographical Analysis
North America Accounted for Approximately 40.2% of the Market Share in 2022 Due To Technologically Advanced Healthcare Infrastructure
North America holds the largest market share in the clinical risk grouping solutions market due to its technologically advanced healthcare infrastructure. Several factors contribute to North America's dominance in this market such as advanced healthcare systems, regulatory environment, financial resources, research and development, quality and patient safety, and emphasis on quality and patient safety.
These factors enable healthcare organizations in the region to readily adopt and implement clinical risk solutions to enhance patient safety and risk management. North American healthcare systems place a strong emphasis on quality improvement and patient safety in the clinical risk grouping solutions market.
Competitive Landscape
The major global players in the market include 3M Company, Optum Inc., Conduent Inc., Lightbeam Health Solutions, Health Catalyst, Change Healthcare, Milliman Inc., COTIVITI Inc., Episource, and Med-IQ Inc.
Why Purchase the Report?
• To visualize the global clinical risk grouping solutions market segmentation based on product, deployment, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of clinical risk grouping solutions market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global clinical risk grouping solutions market report would provide approximately 54 tables, 46 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Deployment
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising focus on value-based care
4.1.2. Restraints
4.1.2.1. Regulatory and legal challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Data Analytics*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Dashboard and Data Visualization Tools
7.4. Risks Reporting Solutions
8. By Deployment
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
8.1.2. Market Attractiveness Index, By Deployment
8.2. Public Cloud*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Private Cloud
8.4. Hybrid Cloud
9. By End-User
9.1. Healthcare service providers
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Clinical Research Organizations
9.3. Pharmaceutical and Biotech Firms
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. 3M Company*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Optum Inc.
12.3. Conduent Inc.
12.4. Lightbeam Health Solutions
12.5. Health Catalyst
12.6. Change Healthcare
12.7. Milliman Inc.
12.8. COTIVITI Inc.
12.9. Episource
12.10. Med-IQ Inc
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

3M Company, 4. Key Developments, Optum Inc., Conduent Inc., Lightbeam Health Solutions, Health Catalyst, Change Healthcare, Milliman Inc., COTIVITI Inc., Episource, Med-IQ Inc

표 목록 (Tables)

List of Tables

Table 1 Global Clinical Risk Grouping Solutions Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Clinical Risk Grouping Solutions Market Value, By Deployment, 2022, 2026 & 2030 (US$

Million)

Table 3 Global Clinical Risk Grouping Solutions Market Value, By End-User, 2022, 2026 & 2030 (US$

Million)

Table 4 Global Clinical Risk Grouping Solutions Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Clinical Risk Grouping Solutions Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Clinical Risk Grouping Solutions Market Value, By Product, 2021-2030 (US$ Million)

Table 7 Global Clinical Risk Grouping Solutions Market Value, By Deployment, 2022, 2026 & 2030 (US$

Million)

Table 8 Global Clinical Risk Grouping Solutions Market Value, By Deployment, 2021-2030 (US$ Million)

Table 9 Global Clinical Risk Grouping Solutions Market Value, By End-User, 2022, 2026 & 2030 (US$

Million)

Table 10 Global Clinical Risk Grouping Solutions Market Value, By End-User, 2021-2030 (US$ Million)

Table 11 Global Clinical Risk Grouping Solutions Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Clinical Risk Grouping Solutions Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Clinical Risk Grouping Solutions Market Value, By Product, 2021-2030 (US$

Million)

Table 14 North America Clinical Risk Grouping Solutions Market Value, By Deployment, 2021-2030 (US$

Million)

Table 15 North America Clinical Risk Grouping Solutions Market Value, By End-User, 2021-2030 (US$

Million)

Table 16 North America Clinical Risk Grouping Solutions Market Value, By Country, 2021-2030 (US$

Million)

Table 17 South America Clinical Risk Grouping Solutions Market Value, By Product, 2021-2030 (US$

Million)

Table 18 South America Clinical Risk Grouping Solutions Market Value, By Deployment, 2021-2030 (US$

Million)

Table 19 South America Clinical Risk Grouping Solutions Market Value, By End-User, 2021-2030 (US$

Million)

Table 20 South America Clinical Risk Grouping Solutions Market Value, By Country, 2021-2030 (US$

Million)

Table 21 Europe Clinical Risk Grouping Solutions Market Value, By Product, 2021-2030 (US$ Million)

Table 22 Europe Clinical Risk Grouping Solutions Market Value, By Deployment, 2021-2030 (US$ Million)

Table 23 Europe Clinical Risk Grouping Solutions Market Value, By End-User, 2021-2030 (US$ Million)

Table 24 Europe Clinical Risk Grouping Solutions Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Clinical Risk Grouping Solutions Market Value, By Product, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Clinical Risk Grouping Solutions Market Value, By Deployment, 2021-2030 (US$

Million)

Table 27 Asia-Pacific Clinical Risk Grouping Solutions Market Value, By End-User, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Clinical Risk Grouping Solutions Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Clinical Risk Grouping Solutions Market Value, By Product, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Clinical Risk Grouping Solutions Market Value, By Deployment, 2021-2030

(US$ Million)

Table 31 Middle East & Africa Clinical Risk Grouping Solutions Market Value, By End-User, 2021-2030 (US$ Million)

Table 32 3M Company: Overview

Table 33 3M Company: Product Portfolio

Table 34 3M Company: Key Developments

Table 35 Optum Inc.: Overview

Table 36 Optum Inc.: Product Portfolio

Table 37 Optum Inc.: Key Developments

Table 38 Conduent Inc.: Overview

Table 39 Conduent Inc.: Product Portfolio

Table 40 Conduent Inc.: Key Developments

Table 41 Lightbeam Health Solutions: Overview

Table 42 Lightbeam Health Solutions: Product Portfolio

Table 43 Lightbeam Health Solutions: Key Developments

Table 44 Health Catalyst: Overview

Table 45 Health Catalyst: Product Portfolio

Table 46 Health Catalyst: Key Developments

Table 47 Change Healthcare: Overview

Table 48 Change Healthcare: Product Portfolio

Table 49 Change Healthcare: Key Developments

Table 50 Milliman Inc.: Overview

Table 51 Milliman Inc.: Product Portfolio

Table 52 Milliman Inc.: Key Developments

Table 53 COTIVITI Inc.: Overview

Table 54 COTIVITI Inc.: Product Portfolio

Table 55 COTIVITI Inc.: Key Developments

Table 56 Episource: Overview

Table 57 Episource: Product Portfolio

Table 58 Episource: Key Developments

Table 59 Med-IQ Inc.: Overview

Table 60 Med-IQ Inc.: Product Portfolio

Table 61 Med-IQ Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 2 Global Clinical Risk Grouping Solutions Market Share, By Product, 2022 & 2030 (%)

Figure 3 Global Clinical Risk Grouping Solutions Market Share, By Deployment, 2022 & 2030 (%)

Figure 4 Global Clinical Risk Grouping Solutions Market Share, By End-User, 2022 & 2030 (%)

Figure 5 Global Clinical Risk Grouping Solutions Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Clinical Risk Grouping Solutions Market Y-o-Y Growth, By Product, 2022-2030 (%)

Figure 7 Data Analytics Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 8 Dashboard and Data Visualization Tools Clinical Risk Grouping Solutions Market Value, 2021-

2030 (US$ Million)

Figure 9 Risks Reporting Solutions Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$

Million)

Figure 10 Global Clinical Risk Grouping Solutions Market Y-o-Y Growth, By Deployment, 2022-2030 (%)

Figure 11 Public Cloud Deployment in Global Clinical Risk Grouping Solutions Market Value, 2021-2030

(US$ Million)

Figure 12 Private Cloud Deployment in Global Clinical Risk Grouping Solutions Market Value, 2021-2030

(US$ Million)

Figure 13 Hybrid Cloud Deployment in Global Clinical Risk Grouping Solutions Market Value, 2021-2030

(US$ Million)

Figure 14 Global Clinical Risk Grouping Solutions Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 15 Healthcare service providers End-User in Global Clinical Risk Grouping Solutions Market Value,

2021-2030 (US$ Million)

Figure 16 Clinical Research Organizations End-User in Global Clinical Risk Grouping Solutions Market

Value, 2021-2030 (US$ Million)

Figure 17 Pharmaceutical and Biotech Firms End-User in Global Clinical Risk Grouping Solutions Market

Value, 2021-2030 (US$ Million)

Figure 18 Others End-User in Global Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$

Million)

Figure 19 Global Clinical Risk Grouping Solutions Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 20 North America Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 21 Asia-Pacific Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 22 Europe Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 23 South America Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 24 Middle East and Africa Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 25 North America Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 26 North America Clinical Risk Grouping Solutions Market Share, By Product, 2022 & 2030 (%)

Figure 27 North America Clinical Risk Grouping Solutions Market Share, By Deployment, 2022 & 2030 (%)

Figure 28 North America Clinical Risk Grouping Solutions Market Share, By End-User, 2022 & 2030 (%)

Figure 29 North America Clinical Risk Grouping Solutions Market Share, By Country, 2022 & 2030 (%)

Figure 30 South America Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 31 South America Clinical Risk Grouping Solutions Market Share, By Product, 2022 & 2030 (%)

Figure 32 South America Clinical Risk Grouping Solutions Market Share, By Deployment, 2022 & 2030 (%)

Figure 33 South America Clinical Risk Grouping Solutions Market Share, By End-User, 2022 & 2030 (%)

Figure 34 South America Clinical Risk Grouping Solutions Market Share, By Country, 2022 & 2030 (%)

Figure 35 Europe Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 36 Europe Clinical Risk Grouping Solutions Market Share, By Product, 2022 & 2030 (%)

Figure 37 Europe Clinical Risk Grouping Solutions Market Share, By Deployment, 2022 & 2030 (%)

Figure 38 Europe Clinical Risk Grouping Solutions Market Share, By End-User, 2022 & 2030 (%)

Figure 39 Europe Clinical Risk Grouping Solutions Market Share, By Country, 2022 & 2030 (%)

Figure 40 Asia-Pacific Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 41 Asia-Pacific Clinical Risk Grouping Solutions Market Share, By Product, 2022 & 2030 (%)

Figure 42 Asia-Pacific Clinical Risk Grouping Solutions Market Share, By Deployment, 2022 & 2030 (%)

Figure 43 Asia-Pacific Clinical Risk Grouping Solutions Market Share, By End-User, 2022 & 2030 (%)

Figure 44 Asia-Pacific Clinical Risk Grouping Solutions Market Share, By Country, 2022 & 2030 (%)

Figure 45 Middle East & Africa Clinical Risk Grouping Solutions Market Value, 2021-2030 (US$ Million)

Figure 46 Middle East & Africa Clinical Risk Grouping Solutions Market Share, By Product, 2022 & 2030

(%)

Figure 47 Middle East & Africa Clinical Risk Grouping Solutions Market Share, By Deployment, 2022 &

2030 (%)

Figure 48 Middle East & Africa Clinical Risk Grouping Solutions Market Share, By End-User, 2022 & 2030

(%)

Figure 49 3M Company: Financials

Figure 50 Optum Inc.: Financials

Figure 51 Conduent Inc.: Financials

Figure 52 Lightbeam Health Solutions: Financials

Figure 53 Health Catalyst: Financials

Figure 54 Change Healthcare: Financials

Figure 55 Milliman Inc.: Financials

Figure 56 COTIVITI Inc.: Financials

Figure 57 Episource: Financials

Figure 58 Med-IQ Inc.: Financials